TY  - RPRT
TI  - Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.
AU  - Lephart, P. R.
AU  - Bachman, M. A.
AU  - LeBar, W.
AU  - McClellan, S. W.
AU  - Barron, K.
AU  - Schroeder, L.
AU  - Newton, D. W.
PY  - 2020
DO  - 10.1101/2020.06.04.135616
UR  - https://www.biorxiv.org/content/10.1101/2020.06.04.135616v1
ID  - 10.1101/2020.06.04.135616
ER  -